Detalhe da pesquisa
1.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
N Engl J Med
; 390(6): 497-509, 2024 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324483
2.
A global action agenda for turning the tide on fatty liver disease.
Hepatology
; 79(2): 502-523, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540183
3.
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
N Engl J Med
; 384(12): 1113-1124, 2021 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185364
4.
High concordance between nonalcoholic fatty liver disease and metabolic dysfunction associated steatotic liver disease in the TARGET-NASH real world cohort.
Am J Gastroenterol
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587293
5.
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.
Hepatology
; 78(1): 195-211, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924031
6.
Liver Disease and Cell Therapy: Advances Made and Remaining Challenges.
Stem Cells
; 41(8): 739-761, 2023 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052348
7.
Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table.
Eur Heart J
; 44(39): 4141-4156, 2023 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37448181
8.
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
JAMA
; 331(15): 1287-1297, 2024 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512249
9.
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis.
Gut
; 72(7): 1399-1409, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599683
10.
TGFß1 priming enhances CXCR3-mediated mesenchymal stromal cell engraftment to the liver and enhances anti-inflammatory efficacy.
J Cell Mol Med
; 27(6): 864-878, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36824012
11.
Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver.
J Hepatol
; 79(6): 1557-1565, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562748
12.
The role of neutrophils in alcohol-related hepatitis.
J Hepatol
; 79(4): 1037-1048, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290590
13.
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores.
J Hepatol
; 78(2): 247-259, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36375686
14.
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis.
J Hepatol
; 79(5): 1110-1120, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37517454
15.
A global research priority agenda to advance public health responses to fatty liver disease.
J Hepatol
; 79(3): 618-634, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353401
16.
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.
Hepatology
; 75(1): 219-228, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537988
17.
PDGFRα/Sca-1 Sorted Mesenchymal Stromal Cells Reduce Liver Injury in Murine Models of Hepatic Ischemia-Reperfusion Injury.
Stem Cells
; 40(11): 1056-1070, 2022 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999023
18.
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
Gut
; 71(5): 1006-1019, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001645
19.
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK.
Lancet
; 397(10286): 1770-1780, 2021 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33714360
20.
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement.
Hepatology
; 74(1): 474-482, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486773